Debate erupts over off-label COVID-19 vaccine use for children under the age of five

0
129



After the federal Food and Drug Administration (FDA) delayed authorization of the Pfizer-BioNTech COVID-19 vaccine last week for children under the age of five in the United States, parents are making a passionate plea for its off-label use.

LEAVE A REPLY

Please enter your comment!
Please enter your name here